Syndax Pharmaceuticals (SNDX) Preferred Stock Liabilities (2015)

Syndax Pharmaceuticals' Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $319.1 million for Q4 2015.

• In Q4 2015, Preferred Stock Liabilities changed N/A year-over-year to $319.1 million; the TTM figure through Dec 2015 stood at $319.1 million (changed N/A YoY), while the FY2015 annual figure was $319.1 million, up 117.3% from the prior year.
• Preferred Stock Liabilities for Q4 2015 stood at $319.1 million.
• The five-year high for Preferred Stock Liabilities was $319.1 million in Q4 2015, with the low at $319.1 million in Q4 2015.